EDITORIAL
Published on 23 Dec 2024
Editorial: Benefits and risks of agonist triggering strategies
doi 10.3389/fendo.2024.1538412
- 235 views
- Frontiers in Endocrinology
- Reproduction
- Research Topics
- Benefits and Risks of Agonist Triggering Strategies
Benefits and Risks of Agonist Triggering Strategies
4,465
Total downloads
16k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 13 Dec 2024
Ovarian sensitivity index affects clinical pregnancy and live birth rates in gonadotropin-releasing hormone agonist and antagonist in vitro fertilization cycles
doi 10.3389/fendo.2024.1457435
- 373 views
ORIGINAL RESEARCH
Published on 11 Jul 2024
Risk factors, management, and future fertility of empty follicle syndrome: a retrospective study with real-world data
doi 10.3389/fendo.2024.1424837
- 2,016 views
ORIGINAL RESEARCH
Published on 03 Jul 2024
The effect of gonadotropin-releasing hormone agonist downregulation in conjunction with hormone replacement therapy on endometrial preparation in patients for frozen–thawed embryo transfer
doi 10.3389/fmed.2024.1412126
- 759 views
ORIGINAL RESEARCH
Published on 14 Jun 2024
Effectiveness and safety of GnRH antagonist originator and generic in real-world clinical practice: a retrospective cohort study
doi 10.3389/fendo.2024.1358278
- 979 views
ORIGINAL RESEARCH
Published on 26 Feb 2024
Transcriptome profiling reveals superovulation with the gonadotropin-releasing hormone agonist trigger impaired embryo implantation in mice
doi 10.3389/fendo.2024.1354435
- 2,568 views
- 2 citations
ORIGINAL RESEARCH
Published on 29 Jan 2024
Impact of COVID-19 convalescence on pregnancy outcomes in patients undergoing IVF/ICSI during fresh ART cycles: a retrospective cohort study
doi 10.3389/fendo.2023.1298995
- 1,174 views
- 4 citations
ORIGINAL RESEARCH
Published on 08 Jan 2024
Intramuscular injection of human chorionic gonadotropin as luteal phase support in artificial cycle frozen-thawed embryo transfer does not improve clinical outcomes: a parallel, open-label randomized trial
doi 10.3389/fendo.2023.1283197
- 1,394 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Dec 2023
The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study
doi 10.3389/fendo.2023.1295787
- 1,618 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Sep 2023
LH level on the antagonist administration day as a predictor of the reproductive outcomes in women with normal ovarian function
doi 10.3389/fendo.2023.1232361
- 1,716 views
